Buradasınız

Anasayfa » Content

TURGUT ÖZAL TIP MERKEZİ ERİŞKİN HEMATOLOJİ KLİNİĞİNDEKİ FEBRİL NÖTROPENİK ATAKLARDA SAPTANAN İNFEKSİYONLARIN DEĞERLENDİRİLMESİ

Evaluation of the infections during febrile neutropenic episodes in the adult hematology clinic of Turgut Özal Medical Center

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2000

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Objectives: In this study, we investigated the infectious agents and foci in febrile neutropenic patients in Adult Hematology Clinic of Turgut Ozal Medical Center. Material and methods: Seventy-three febrile neutropenic episodes in 41 patients were evaluated. Results: In 42 febrile neutropenic episodes (58.3%) the microorganism was identified. The infectious foci were urine (n=24), blood (n=13), throat (n=2), wound area (n=l), tip of the catheter (n=l) and sputum (n=l). Conclusion: The determined infectious agents were E co/i (n=17), Coagulase-negative Staphylococcus (n=10), S. aureus (n=6), S. pneumoniae (n=3), K. pneumoniae (n=2), C. albicans (n=2) and P. aeruginosa (n=l).
Bookmark/Search this post with
Abstract (Original Language): 
Amaç: Bu çalışmada Turgut Özal Tıp Merkezi erişkin Hematoloji kliniğinde izlenen febril nötropeni ataklarında saptanan infeksiyon ajanlarını ve infeksiyon odaklarını araştırdık. Materyal ve metot: Kırk bir hastada saptanan 73 febril nötropeni atağı incelendi. Bulgular: Febril nötropeni ataklarından 42'sinde (%58.3) mikroorganizma izole edildi. Yirmidört atakta idrar kültüründe, 13 atakta kan kültüründe, iki atakta boğaz kültüründe, bir atakta yara yeri kültüründe, bir atakta katater ucu kültüründe, bir atakta balgam kültüründe mikroorganizma izole edildi. Sonuç: İzole edilen mikroorganizmalardan 17si E co/i, 10'u Koagülaz-negatif Staphylococcus, altısı S. aureus, üçü S. pneumoniae, ikisi K. pneumoniae, ikisi Candida albicans, biri P. aeruginosa idi.
FULL TEXT (PDF): 
PDF icon arastirmax-turgut-ozal-tip-merkezi-eriskin-hematoloji-klinigindeki-febril-notropenik-ataklarda-saptanan-infeksiyonlarin-degerlendirilmesi.pdf
  • 1
30-33
  • Turkish

REFERENCES

References: 

1.
Akov
a M, Akalın HE. Nötropenik hastalarda ateş. Hacettepe Tıp Dergisi 1988;21:71-3.
2. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64:328-40.
3. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993;18:1323-32.
4. Wade JC. Epidemiology and prevention of infection in the comprimised host. In: Rubin RH, Young LS (eds). Clinical Approach to Infection in the Comprimised Host. 3rd ed. New York: Plenum Medical Book Company, 1994:5-31.
5. Akova
M
. Kanserli hastalarda infeksiyon hastalıklarının tedavi ilkeleri. Antibiyotik Bülteni 1994;4:10-4.
6.
Akov
a M (moderator): Kanserli nötropenik hastaya yaklaşım. Hacettepe Tıp Dergisi 1995;26:31-6.
7. Sandin RL, Rinaldi M. Special cosiderations for the clinical microbiology laboratory in the diagnosis of infections in the cancer patients. Infect Dis Clin Noth Am 1996;10:423-30.
8. Klastersky 1 Therapy of infections in cancer patients. In: Klastersky J, Schimpff SC, Senn H-J (eds). Handbook of Supportive Care in Cancer. New York: Marcel Dekker, Inc, 1995:1-44.
9. Akova
M
, Akalın HE, Çatakoğlu N, ve ark. Ateşli nötropenik hastalarda infeksiyonların dağılımı: 218 ateşli atağın incelenmesi. Hacettepe Tıp Dergisi 1989;22:227-31.
33
Turgu
t Özal Tıp Merkezi Dergisi 7(1):2000
10.
Akov
a M. Özel konakta infeksiyonlar. infeksiyon Hastalıkları Kitabı. Editörler: Topçu AW, Söyletir G, Doğanay M. İstanbul: Nobel Tıp Kitabevi, 1997;291-9.
11. Uzun Ö, Hayran M, Akova A, et al. Gram-negative bacteremia in cancer patients: clinical featuresand factors influencing prognosis in 200 episodes. Turkish J Cancer 1993;23:17-21.
12. Klastersky J, Zinner Sh, Calandra T, et al. and the EORTC International Antimicrobial Cooperative Group. Ampiric antimicrobial therapy for febril granulocytopenic cancer patients: Lessons from four EORTC trials. Eur J Cancer Clin Oncol 1988;24:s35.
13. Akova M, Hayran M, Ünal S, et al. Characteristics of infectious agents in adult cancer patients with neutropenia and fever. 13th Meeting of the International Society of Haematology. Abstract no. 633. 3-8 September 1995, Istanbul, Türkiye.
14. Akova M, Akan H, Hayran M, et al. and the Meropenem Study Group. Multicenter trial of meropenem versus amikacin plus ceftazidime for the initial empirical treatment of febrile neutropenic patients. 9th International symposium on Infections in the Immunocompromised Host. Abstract no. 21. June 23-26, 1996, Assisi, Italy.
15. Rubin RH. Fungal and bacterial infections in the immunocompromised host. Eur J Clin Microbiol Infect Dis 1993; 12 (suppl l):42-8.
16. Ben Ali A. Neutropenia with fever. Presse Med 1999;28 Suppl 3:9-10.
17. Oppenheim BA. The changing pattern of infection in neutropenic patients. J Antimicrob Chemother 1998;41 Suppl D:7-ll.

Thank you for copying data from http://www.arastirmax.com